JPWO2023210713A5 - - Google Patents

Info

Publication number
JPWO2023210713A5
JPWO2023210713A5 JP2024518006A JP2024518006A JPWO2023210713A5 JP WO2023210713 A5 JPWO2023210713 A5 JP WO2023210713A5 JP 2024518006 A JP2024518006 A JP 2024518006A JP 2024518006 A JP2024518006 A JP 2024518006A JP WO2023210713 A5 JPWO2023210713 A5 JP WO2023210713A5
Authority
JP
Japan
Application number
JP2024518006A
Other languages
Japanese (ja)
Other versions
JPWO2023210713A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/016537 external-priority patent/WO2023210713A1/ja
Publication of JPWO2023210713A1 publication Critical patent/JPWO2023210713A1/ja
Publication of JPWO2023210713A5 publication Critical patent/JPWO2023210713A5/ja
Pending legal-status Critical Current

Links

JP2024518006A 2022-04-27 2023-04-26 Pending JPWO2023210713A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022073500 2022-04-27
PCT/JP2023/016537 WO2023210713A1 (ja) 2022-04-27 2023-04-26 心外膜細胞再生促進剤および心外膜細胞の再生促進方法

Publications (2)

Publication Number Publication Date
JPWO2023210713A1 JPWO2023210713A1 (https=) 2023-11-02
JPWO2023210713A5 true JPWO2023210713A5 (https=) 2026-05-08

Family

ID=88518739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518006A Pending JPWO2023210713A1 (https=) 2022-04-27 2023-04-26

Country Status (4)

Country Link
US (1) US20250290076A1 (https=)
EP (1) EP4516905A4 (https=)
JP (1) JPWO2023210713A1 (https=)
WO (1) WO2023210713A1 (https=)

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
ATE469654T1 (de) * 2003-12-30 2010-06-15 Augustinus Bader Verwendung des erythropoietins zur regeneration von lebergewebe
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
JP5813321B2 (ja) 2007-03-23 2015-11-17 ウィスコンシン アラムニ リサーチ ファンデーション 体細胞の再プログラム化
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
ES2799897T3 (es) 2007-08-31 2020-12-22 Whitehead Inst Biomedical Res Estimulación de la vía wnt en la reprogramación de células somáticas
KR101564044B1 (ko) 2007-10-31 2015-10-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 핵초기화 방법
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
WO2009079007A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
US20100330677A1 (en) 2008-02-11 2010-12-30 Cambridge Enterprise Limited Improved Reprogramming of Mammalian Cells, and Cells Obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
WO2009102983A2 (en) 2008-02-15 2009-08-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
MX2010010165A (es) 2008-03-17 2010-11-25 Scripps Research Inst Procedimientos quimicos y geneticos combinados para generacion de celulas madre pluripotentes inducidas.
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
KR20110019727A (ko) 2008-04-07 2011-02-28 뉴포텐셜, 인크. Rna 간섭을 통한 다능 유전자의 유도에 의한 세포 재프로그래밍
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
US9453204B2 (en) 2008-07-14 2016-09-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/ARID3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
JP2012507258A (ja) 2008-10-30 2012-03-29 国立大学法人京都大学 人工多能性幹細胞の作製方法
US20110059526A1 (en) 2008-11-12 2011-03-10 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
EP2376626A4 (en) 2008-12-13 2012-10-17 Dna Microarray MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
WO2010098419A1 (en) 2009-02-27 2010-09-02 Kyoto University Novel nuclear reprogramming substance
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010115050A2 (en) 2009-04-01 2010-10-07 The Regents Of The University Of California Embryonic stem cell specific micrornas promote induced pluripotency
WO2010124290A2 (en) 2009-04-24 2010-10-28 Whitehead Institute For Biomedical Research Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
WO2014006020A1 (en) * 2012-07-02 2014-01-09 Fibrostatin, S.L. Gpbp-1 inhibition and its therapeutic use
US10264976B2 (en) * 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
US10682416B2 (en) * 2015-04-09 2020-06-16 Regencor, Inc. Epicardial-derived paracrine factors for repairing cardiac tissue
JP7620938B2 (ja) * 2019-07-30 2025-01-24 ビクター チャン カーディアック リサーチ インスティテュート Klf誘導心筋再生

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023008688A2 (https=)
JPWO2023210713A1 (https=)
JPWO2023210713A5 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR102022017795A2 (https=)
CN307046913S (https=)
BY13159U (https=)
BY13153U (https=)
CN307046205S (https=)
CN307045539S (https=)
CN307044623S (https=)
CN307044489S (https=)
BY13168U (https=)
CN307047533S (https=)
BY13166U (https=)
BY13165U (https=)
CN307047719S (https=)
CN307048553S (https=)